Neuromodulation : journal of the International Neuromodulation Society
-
Among the surgical treatment options for patients with medically refractory dystonia chronic deep brain stimulation (DBS) of different targets in the basal ganglia circuitry has become one of the most important tools. The globus pallidus internus nowadays is the target of choice, while there is only limited experience with other targets. At this time, patients with primary (genetic or sporadic) generalized and segmental dystonia, and patients with (complex) cervical dystonia are thought to be the best candidates for pallidal DBS. ⋯ We also provide an overview on DBS surgery in less common dystonic syndromes, such as craniofacial dystonia, status dystonicus, task-specific dystonia, paroxysmal dystonia, camptocormia, and secondary dystonias, including choreoathetosis, hemidystonia, tardive dystonia, and pantothenate kinase-associated neurodegeneration. Furthermore, we discuss the implications of intra-operative microelectrode recordings and pallidal field potentials for the pathophysiology of dystonia and the particular possible mechanisms of DBS in dystonia. Finally, future perspectives are outlined.
-
Objectives. This study aims to demonstrate the utility of spinal cord stimulation in a neuropathic pain syndrome and overall decline in health and functional independence following elapid envenomation in a morbidly obese, insulin-dependent diabetic. Materials and Methods. A two-lead, 16-electrode constant-current, independently controlled system is placed in the mid-cervical spine. Results. Noted were a improvement in overall health status with better glycemic control and return to work status in response to adequate pain control. Conclusions. The case serves as a model for other orphan pain cases with a seemingly esoteric etiology and adds to the existing body of literature that spinal cord stimulation and neuromodulation, in general, has a wide-ranging applicability peripheral neuropathic pain syndromes.
-
Objective. This study aims to assess peripheral nerve field stimulation as a treatment option for chronic pain and test for indicators of outcome. Materials and Methods. We reviewed all patients permanently implanted with peripheral nerve field stimulators over the past 24 months. A questionnaire was used to assess outcomes. ⋯ Most patients reported decreases in analgesic use after treatment. Pain relief was significantly and highly correlated with reduced analgesic intake and patient satisfaction. Conclusion. Peripheral nerve field stimulation is a safe, reversible, and effective treatment option for patients with chronic pain, particularly those under 60 years.
-
Objectives. The problem of treating patients in a vegetative state remains grossly unresolved, and spinal cord stimulation (SCS) had seemed promising in some studies, suggesting, to us, further study. Materials and Methods. A prospective uncontrolled and nonrandomized observational study for 20 consecutive years (1986-2005) was performed on the effect of SCS in 214 patients in persistent vegetative state (PVS) that resulted from global anoxia and/or, stroke and/or head injury. ⋯ Results. Excellent and positive results were obtained in 109 of 201 patients (54%), but better in those patients below the age of 35, those of PVS of traumatic origin and those patients with regional cerebral blood flow over 20 mL/100 g/min. Conclusions. These findings, though inconclusive of actual benefit of SCS for PVS, indicate to us that further evidence-based, randomized controlled trials are needed to confirm efficacy of the treatment and define those who are going to benefit from this treatment method.
-
Objectives. The pain associated with herpes zoster can be classified as acute phase, persistent phase, or chronic phase, but if it is prolonged, it becomes resistant to treatment. It is clinically important to prevent transition to postherpetic neuralgia after the onset of herpes zoster, and the outcome depends on whether continuous and potent pain management can be achieved between the acute and persistent phases. We evaluated the effect of pain management leading to quick termination of pain using temporary spinal cord stimulation (SCS) which does not require implantation of a device. ⋯ Less epidural analgesia was required and the adverse reactions of lowered blood pressure in three cases and urinary retention in seven cases disappeared soon. The self-rated satisfaction was higher with SCS than with CEB in all 14 cases, because it is highly controllable and has minimal activities of daily living-lowering effects. Conclusion. Temporary SCS, which does not require implantation of a device, may have a potent analgesic effect on severe pain in patients in the persistent phase after herpes zoster, and prevent transition to postherpetic neuralgia.